University of California-Los Angeles
Los Angeles, California 99095
183 studies enrolling now · 844 studies all time
What they study most
160 Participants Aged 18-35 Years and Obese (BMI ≥30) Open to Men and Women of All Ethnicity, ADA SCID, ADHD, ADPKD, AIDS, ALS, AML With Gene Mutations, ANXIETY DISORDERS (or Anxiety and Phobic Neuroses), APDS, ASD, ASXL1 Gene Mutation, ASXL2 Gene Mutation
Studies at this site
- Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS) — Recruiting now
- A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids) — Recruiting now
- Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes — Recruiting now
- Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread — Recruiting now
- A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis — Recruiting now
- PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease — Recruiting now
- A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases — Recruiting now
- A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast — Recruiting now
- A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — Recruiting now
- A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS) — Recruiting now
- A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis — Recruiting now
- Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC) — Recruiting now
- Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease — Recruiting now
- Telerehabilitation In The Home After Stroke — Recruiting now
- PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis — Recruiting now
- Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias — Recruiting now
- A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis — Recruiting now
- Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) — Recruiting now
- Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients — Recruiting now
- A Long-term Extension Study of PCI-32765 (Ibrutinib) — Recruiting now
- Multi-Center Clean Air Randomized Controlled Trial in COPD — Recruiting now
- ASSESS ALL ALS Study — Recruiting now
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) — Recruiting now
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma — Recruiting now
- Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL — Recruiting now
- AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors — Recruiting now
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease — Recruiting now
- Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network — Recruiting now
- Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML — Recruiting now
- Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT — Recruiting now
- Determining the Role of Social Reward Learning in Social Anhedonia — Recruiting now
- Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease — Recruiting now
- Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma — Recruiting now
- AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas — Recruiting now
- A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) — Recruiting now
- PSMA PET Combined With MRI for the Detection of PCa — Recruiting now
- COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction — Recruiting now
- Prescription of Letrozole for Uterine Myoma — Recruiting now
- RA-PRO PRAGMATIC TRIAL — Recruiting now
- Deep Functional Phenotyping of the ALA Lung Health Cohort — Recruiting now
- Comprehensive HHT Outcomes Registry of the United States (CHORUS) — Recruiting now
- Social Facilitation of Emotion Regulation in Adolescence — Recruiting now
- Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) — Recruiting now
- Nutrition for Precision Health, Powered by the All of Us — Recruiting now
- EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety — Recruiting now
- Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer — Recruiting now
- Automated Insulin for Management of Intrapartum Glycemia — Recruiting now
- Colchicine to Reduce Your SympToms And Lower Levels of Inflammation, Zeroing in on Effective CPPD Disease Treatment — Recruiting now
- Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry — Recruiting now
- The STOP-MED CTRCD Trial — Recruiting now